Advertisement
U.S. markets close in 2 hours 43 minutes
  • S&P 500

    5,249.71
    +1.22 (+0.02%)
     
  • Dow 30

    39,753.91
    -6.17 (-0.02%)
     
  • Nasdaq

    16,370.71
    -28.81 (-0.18%)
     
  • Russell 2000

    2,126.66
    +12.31 (+0.58%)
     
  • Crude Oil

    82.78
    +1.43 (+1.76%)
     
  • Gold

    2,241.80
    +29.10 (+1.32%)
     
  • Silver

    24.96
    +0.21 (+0.84%)
     
  • EUR/USD

    1.0803
    -0.0027 (-0.25%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • GBP/USD

    1.2629
    -0.0009 (-0.07%)
     
  • USD/JPY

    151.3690
    +0.1230 (+0.08%)
     
  • Bitcoin USD

    70,616.49
    +1,293.59 (+1.87%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Endexx Announces Global CBD License & Distribution Deal With Cannabis Infusion Brand the Mad Hatter Coffee & Tea Co.

First Product Launch Third Eye Chai Catered to Global Health and Whole Foods Markets

Coming Soon CBD Click here for high-resolution version

CAVE CREEK, AZ--(Marketwired - May 11, 2016) - Endexx Corporation (OTC PINK: EDXC), a provider of innovative phyto-nutrient based food and nutritional products, announced today a license and distribution deal with The Mad Hatter Coffee & Tea Co., to deliver Cannabidiol (CBD) rich beverages that will be available globally.

The Mad Hatter Coffee & Tea Co. has led the niche market of cannabis-infused gourmet organic coffee and tea beverages since 2007, and is a true pioneer in cannabis-infused edible brands with beverage products currently available in 7 legalized states and over 2000 stores in the U.S. The Mad Hatter has been profiled by Newsweek, Time, The New York Times, and other major publications.

The collaboration offers a major opportunity to bring specific hemp and CBD-infused natural blends to the global health and whole foods markets, a major step for the cross-over markets valued at over $3 billion. As a result, Endexx will launch its first product to showcase the Third Eye Chai, a masala chai tea available in brew bags for individual use in multi-packs. In addition, the companies are in development for other bottled drinks and environmentally friendly K-cups.

Endexx CEO, Todd Davis, stated, "The Mad Hatter team and Endexx have been collaborating together for the past year. Their products are of the highest quality and exceed all expectations as a nutrition-based product to be infused with CBD and other phytonutrients. With the addition of our recently contracted Food Broker Network, we have positioned the company to be a leading distributor and product innovator in the hemp nutrition and health arena. Our studies of this plant-based naturally occurring molecule have demonstrated that both people and pets will achieve significant health benefits and noticeable changes in their daily lives. Our objective is to develop and distribute products that naturally fight pain and inflammation, while supporting the body's natural immune health system."

Jill Alikas St. Thomas, Cofounder of The Mad Hatter Coffee & Tea, said, "Our mission has always been to serve the patient. We research, design and expand our product lines for true patient needs and concerns. Joining forces with Endexx will allow Mad Hatter to broaden the reach of healthy alternatives into pharmaceuticals in a world ready to embrace proactive health practices. The analogous objectives we share with Endexx and their expertise of phyto-nutrients makes this a strong union."

The 3rd ArcView State of Legal Marijuana Markets report found that if legalized nationwide, the marijuana market would surpass the $33.1 billion organic food industry by about $3 billion. Organic foods currently bring about $33 billion each year, and it is estimated that the legal marijuana market could bring in closer to $36 billion each year once every state ends prohibition.

About Endexx

Endexx provides innovative medical marijuana management and technology solutions. Endexx, with its collaborative partners and consultants, develops and distributes consumable product lines derived from industrial hemp that is GMO and pesticides free and naturally rich in phytocannabinoids. The company has two technology products and services that launched in 2014 -- the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to the eventual federal mandates. The Autospense™ is a high-tech marijuana inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailer, while enhancing their service quality by reducing transaction time for customers. Websites include: www.cbdunlimited.com, www.cbdhealthsolutions.com, www.endexx.com, www.m3hub.com.

Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3006283

Advertisement